In lung adenocarcinomas bearing a NK2 homeobox 1 (NKX2-1) amplification, the oncogenic capacity of LMO3 as a transcription regulator downstream of NKX2-1 has been demonstrated [59]. The gene discussed is NKX2-1; the disease is lung adenocarcinoma.